SCHEMBL5752674

SCHEMBL5752674

O=C(O)C=Cc1ccc(-c2ncc[nH]2)c(-c2ccc3ccccc3c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 4/20 0.51
CDK8 P49336 4/20 0.51
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
CSNK1A1 P48729 1/20 0.41
TYRO3 Q06418 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
BACE1 P56817 1/20 0.41
RAB9A P51151 1/20 0.41
RXRA P19793 1/20 0.40
NR4A2 P43354 1/20 0.40
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5752989 0.85 CCNC (0.56) CCNCCDK8ADRA2AADRA2BADRA2C
SCHEMBL11833573 0.76 KDM4E (0.59) PIM2ESR1KDM4EALDH1A1
SCHEMBL11833578 0.76 KDM4E (0.59) PIM2ESR1KDM4EALDH1A1
SCHEMBL5748903 0.76 CCNC (0.51) CCNCCDK8ADRA2AADRA2BADRA2C
SCHEMBL5914832 0.74 ADRA2A (0.44) ADRA2AADRA2BADRA2CCSNK1A1TYRO3
SCHEMBL5914848 0.73 NISCH (0.41) ADRA2AADRA2BADRA2CCSNK1A1TYRO3
SCHEMBL17403503 0.73 HDAC2 (0.58) CCNCCDK8BACE1RAB9AAKR1C4
SCHEMBL6552210 0.73 RELA (0.62) BACE1RAB9ACYP1A1CYP1A2CYP3A4
SCHEMBL78426 0.73 RELA (0.62) BACE1RAB9ACYP1A1CYP1A2CYP3A4
SCHEMBL78427 0.73 RELA (0.62) BACE1RAB9ACYP1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660427-A4 SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2006-12-20 EP disclosed
EP-1660427-A1 SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2006-05-31 EP disclosed
WO-2005016862-A1 SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORPORATION (JP) 2005-02-24 WO disclosed